Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016092933> ?p ?o ?g. }
- W2016092933 endingPage "256" @default.
- W2016092933 startingPage "250" @default.
- W2016092933 abstract "Chemokines, originally discovered as mediators of directional migration of immune cells to sites of inflammation and injury, have a function beyond their role in leukocyte chemotaxis. Indeed, they participate in organ development, angiogenesis, tumourigenesis and, more importantly, in the immune response. The chemokine family characterized by four highly conserved cysteine amino acid residues, with two cysteine residues (C) and a non-cysteine amino acid (X) between them (CXC), is known for its ability to promote trafficking of various leukocytes and to regulate angiogenesis and vascular remodelling. Intriguingly, the presence or absence of a structural-functional domain constituted by glutamic acid–leucine–arginine motif that precedes the first cysteine amino acid residue accounts for their unique property to induce or inhibit angiogenesis (angiogenic or angiostatic activity). The ability of CXC chemokine receptor 3 to promote Th1-dependent immunity and, at the same time, inhibit angiogenesis (immunoangiostasis) is of critical importance for inducing tumour regression. Agents that are able to inhibit angiogenic activities or promote angiostatic activities of CXC chemokines are future targets for research on cancer treatment. Here, we review insights on CXC chemokines in the context of immunoangiostasis and vascular damage." @default.
- W2016092933 created "2016-06-24" @default.
- W2016092933 creator A5022257984 @default.
- W2016092933 creator A5027814946 @default.
- W2016092933 creator A5041337705 @default.
- W2016092933 creator A5061269136 @default.
- W2016092933 date "2008-02-19" @default.
- W2016092933 modified "2023-09-28" @default.
- W2016092933 title "Understanding the immunoangiostatic CXC chemokine network" @default.
- W2016092933 cites W1500954694 @default.
- W2016092933 cites W1521747187 @default.
- W2016092933 cites W1557239654 @default.
- W2016092933 cites W1586392520 @default.
- W2016092933 cites W1607819524 @default.
- W2016092933 cites W172579969 @default.
- W2016092933 cites W1751960924 @default.
- W2016092933 cites W1879346051 @default.
- W2016092933 cites W1919452972 @default.
- W2016092933 cites W1965037168 @default.
- W2016092933 cites W1965207164 @default.
- W2016092933 cites W1968849357 @default.
- W2016092933 cites W1976815754 @default.
- W2016092933 cites W1985804036 @default.
- W2016092933 cites W1994512364 @default.
- W2016092933 cites W1994803737 @default.
- W2016092933 cites W1998605540 @default.
- W2016092933 cites W2002358634 @default.
- W2016092933 cites W2005654322 @default.
- W2016092933 cites W2005659566 @default.
- W2016092933 cites W2010463369 @default.
- W2016092933 cites W2010476650 @default.
- W2016092933 cites W2010638326 @default.
- W2016092933 cites W2013608409 @default.
- W2016092933 cites W2023624246 @default.
- W2016092933 cites W2027853368 @default.
- W2016092933 cites W2029790299 @default.
- W2016092933 cites W2029824788 @default.
- W2016092933 cites W2030384822 @default.
- W2016092933 cites W2050428812 @default.
- W2016092933 cites W2054425276 @default.
- W2016092933 cites W2056088187 @default.
- W2016092933 cites W2059614508 @default.
- W2016092933 cites W2061814831 @default.
- W2016092933 cites W2062036842 @default.
- W2016092933 cites W2066413229 @default.
- W2016092933 cites W2067409782 @default.
- W2016092933 cites W2074391347 @default.
- W2016092933 cites W2081596482 @default.
- W2016092933 cites W2088873819 @default.
- W2016092933 cites W2091040274 @default.
- W2016092933 cites W2091647214 @default.
- W2016092933 cites W2095968162 @default.
- W2016092933 cites W2098509726 @default.
- W2016092933 cites W2100852741 @default.
- W2016092933 cites W2115850686 @default.
- W2016092933 cites W2121479816 @default.
- W2016092933 cites W2128417084 @default.
- W2016092933 cites W2129416247 @default.
- W2016092933 cites W2129941826 @default.
- W2016092933 cites W2132084960 @default.
- W2016092933 cites W2135421977 @default.
- W2016092933 cites W2136451405 @default.
- W2016092933 cites W2140641560 @default.
- W2016092933 cites W2143372911 @default.
- W2016092933 cites W2143408828 @default.
- W2016092933 cites W2150341008 @default.
- W2016092933 cites W2151453636 @default.
- W2016092933 cites W2156323704 @default.
- W2016092933 cites W2157329817 @default.
- W2016092933 cites W2161199652 @default.
- W2016092933 cites W2162063105 @default.
- W2016092933 cites W2162727767 @default.
- W2016092933 cites W2165976939 @default.
- W2016092933 cites W2168669893 @default.
- W2016092933 cites W2170547143 @default.
- W2016092933 cites W72344367 @default.
- W2016092933 cites W2140575920 @default.
- W2016092933 doi "https://doi.org/10.1093/cvr/cvn029" @default.
- W2016092933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18252760" @default.
- W2016092933 hasPublicationYear "2008" @default.
- W2016092933 type Work @default.
- W2016092933 sameAs 2016092933 @default.
- W2016092933 citedByCount "60" @default.
- W2016092933 countsByYear W20160929332012 @default.
- W2016092933 countsByYear W20160929332013 @default.
- W2016092933 countsByYear W20160929332014 @default.
- W2016092933 countsByYear W20160929332015 @default.
- W2016092933 countsByYear W20160929332016 @default.
- W2016092933 countsByYear W20160929332017 @default.
- W2016092933 countsByYear W20160929332018 @default.
- W2016092933 countsByYear W20160929332019 @default.
- W2016092933 countsByYear W20160929332020 @default.
- W2016092933 countsByYear W20160929332021 @default.
- W2016092933 countsByYear W20160929332022 @default.
- W2016092933 countsByYear W20160929332023 @default.
- W2016092933 crossrefType "journal-article" @default.
- W2016092933 hasAuthorship W2016092933A5022257984 @default.
- W2016092933 hasAuthorship W2016092933A5027814946 @default.